Showing results (1161-1170 of 15,775) with videos related to

Sort By:
Pageof 1,578
The Journal of Antimicrobial Chemotherapy|June 1, 1995
Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% creamM T Borin, G W Powley, K R Tackwell, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1995
A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A beta-haemolytic streptococciC Carbon, A Chatelin, E Bingen, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1995
The in-vitro activity of CP 99,219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agentsJ Child, J Andrews, F Boswell, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1997
A molecular analysis of Greek and UK Haemophilus influenzae conjugative resistance plasmidsI D Dimopoulou, J Z Jordens, N J Legakis, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1997
Evaluation of Innofluor fluorescence polarization immunoassay kits for the determination of serum concentrations of gentamicin, tobramycin, amikacin and vancomycin.lesassays@ukneqasaa.win-uk.netL O White, H A Holt, D S Reeves, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1997
Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibioticsG P Gui, P R Thomas, M L Tizard, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1997
In-vitro ranking of the efficacy of antimicrobial agentsY Tajima
The Journal of Antimicrobial Chemotherapy|March 1, 1997
Therapeutic effects of cefozopran against experimental mixed urinary tract infection with Enterococcus faecalis and Pseudomonas aeruginosa in miceN Tsuchimori, T Yamazaki, K Okonogi
The Journal of Antimicrobial Chemotherapy|February 1, 1997
New therapeutic approaches to the alphaherpesvirus infectionsK A Cassady, R J Whitley
The Journal of Antimicrobial Chemotherapy|February 1, 1997
Comparative in-vitro activity of meropenem against selected pathogens from hospitalized patients in The Netherlands. MASTIN Study GroupH P Endtz, W C van Dijk, H A Verbrugh
Pageof 1,578